Countable Labs has said it has raised $26 million to accelerate its clinical product development and the global commercialisation of Countable PCR. The biotechnology company raised the capital in an oversubscribed financing round, which will allow it to leverage capabilities to support cell and gene therapy, minimal residual… Read More
Join DDW and Thermo Fisher Scientific on 20 June, 11AM EDT/4PM BST, for an exclusive webinar, ‘Advancing biotherapy manufacturing: innovative strategies for residual DNA and viral titre quantitation using dPCR’. This free event will feature insight from Thermo Fisher Scientific’s Jonas Buege, Senior… Read More
Join DDW and Thermo Fisher Scientific on 20 June, 11AM EDT/4PM BST, for an exclusive webinar, ‘Advancing biotherapy manufacturing: innovative strategies for residual DNA and viral titre quantitation using dPCR’. This free event will feature insight from Thermo Fisher Scientific’s Jonas Buege, Senior… Read More
Join DDW and Thermo Fisher Scientific on 20 June, 11AM EDT/4PM BST, for an exclusive webinar, ‘Advancing biotherapy manufacturing: innovative strategies for residual DNA and viral titre quantitation using dPCR’. This free event will feature insight from Thermo Fisher Scientific’s Jonas Buege, Senior… Read More
Join DDW and Thermo Fisher Scientific on 20 June, 11AM EDT/4PM BST, for an exclusive webinar, ‘Advancing biotherapy manufacturing: innovative strategies for residual DNA and viral titre quantitation using dPCR’. This free event will feature insight from Thermo Fisher Scientific’s Jonas Buege, Senior… Read More
Leveraging digital PCR-based assays for the quantitation of residual host cell DNA or viral titres within a biotherapeutic manufacturing workflow offers significant value in ensuring product quality and safety. Digital PCR, or dPCR, is a highly sensitive and precise technique that enables the absolute quantification of nucleic acid targets. In… Read More
A new Whitepaper is available from Thermo Fisher Scientific, entitled ‘Lentiviral vector characterization for cell and gene therapy manufacturing using the QuantStudio Absolute Q Digital PCR System’. Recombinant lentiviral vectors are used for ex vivo transgene delivery in several gene-modified cell therapies, such as chimeric antigen receptor (CAR) T cell therapy. Read More
Recombinant lentiviral vectors are used for ex vivo transgene delivery in several gene-modified cell therapies, such as chimeric antigen receptor (CAR) T cell therapy. Reliable analytical methods such as digital PCR to characterise lentiviral vectors and the cells transduced with them are critical to helping ensure the safety and efficacy of… Read More
The term ‘PCR’ has been on everybody’s lips since the outbreak of the Covid-19 pandemic, but only laboratory professionals know how difficult it can be to achieve success with this well-established technique. If your PCR reactions are driving you to despair, look no further than INTEGRA’s comprehensive… Read More
The term ‘PCR’ has been on everybody’s lips since the outbreak of the Covid-19 pandemic, but only laboratory professionals know how difficult it can be to achieve success with this well-established technique. If your PCR reactions are driving you to despair, look no further than INTEGRA’s comprehensive eBook! Learn more… Read More
Find out what’s new in the world of tools and services for the drug discovery industry with our update below. CFX Opus Deepwell Dx Real-Time PCR System – Bio-Rad Laboratories Bio-Rad Laboratories has launched the CFX Opus Deepwell Dx Real-Time PCR System, which offers accurate and precise quantification… Read More
Monitoring wastewater for SARS-CoV-2 – or Coronavirus as it is more commonly known – can be a valuable data resource for an effective Covid-19 management. However, there are several challenges involved in detecting biological parameters in wastewater. Fortunately, there are also several solutions available to overcome them. Wastewater can be… Read More
SPT Labtech recently opened a new office to maximise on Japanese biotech growth. Lu Rahman caught up with Director Masahiro Matsushita, to find out about the region and the opportunities for drug discovery. LR: Tell me about the company’s experience in the Japanese biotech market in Japan – how… Read More
As the demand for assay data continues to grow and enabling technology allows us to generate huge datasets at impressive speeds, assay design is as critical as ever says Brian, Kirk, Vice President, Business Development, BioDot. While assay scaling has obvious benefits with respect to data analysis and providing answers… Read More
By Ibis Sanchez-Serrano and Rathnam Chaguturu Mitigation of COVID-19 pandemic requires a combination of effective epidemiological policies and the discovery/development of powerful drugs against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) that causes this disease. This article examines the major initiatives being explored at the… Read More
By Richard Gray The recent outbreak of COVID-19 has highlighted the need for fast and efficient development and production of vaccines for a whole gamut of pathogens, old and new. Microfluidics technologies can be used to accelerate the vaccine development process in a number of ways,… Read More
